• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA LIFESCIENCES CORP DURASEAL 5ML 5 KITS/BOX CE APPROVED; DURASEAL CRANIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA LIFESCIENCES CORP DURASEAL 5ML 5 KITS/BOX CE APPROVED; DURASEAL CRANIAL Back to Search Results
Catalog Number DSD5005
Device Problem Chemical Problem (2893)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/23/2021
Event Type  malfunction  
Manufacturer Narrative
Attempts are being made to obtain additional information.Upon completion of the investigation, a follow-up report will be submitted.
 
Event Description
This is 3 of 3 reports linked to mfg report numbers: 3003418325-2021-00001, 3003418325-2021-00002.A facility reported that duraseal (dsd5005) was thinner than normal.The patient was prepped for surgery and the product was in contact with the patient.There was no delay in surgery, and the case continued as planned using the thinner duraseal and no adverse impact to patient was reported.Additional information has been requested.
 
Manufacturer Narrative
Duraseal sample with 4 sealed, complete and unused polymer kits were returned for evaluation: device history record (dhr): the dhr review and product analysis of the product returned concluded there were no component or assembly component related failures with the returned product or at the time of release.Failure analysis - the sample received was a finished good box with 4 sealed, complete and unused polymer kits.All kits were reviewed and no issues were found with them, they all met release criteria.All 4 kits were opened, the peg vial activated and the phosphate syringe mixed with the peg powder.Afterwards the reconstituted peg+phospate were assembled with the y connector +spray tip+borate syringe to form the duraseal gel.No issues with any of the components or with forming of the gel upon shooting and combining per the ifu.The reported condition could not be confirmed.Root cause - the reported condition was not confirmed.The root cause is undetermined and was unable to be confirmed in the samples and complaint evaluation.A dhr review and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.Product was received for analysis and the investigation could not confirm the complaint reported condition.Per the fmea, potential causes of failure include: performance, adhesion barrier.The risk remains acceptable per the risk analysis.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL 5ML 5 KITS/BOX CE APPROVED
Type of Device
DURASEAL CRANIAL
Manufacturer (Section D)
INTEGRA LIFESCIENCES CORP
1100 campus drive
1100 campus drive
princeton NJ 08540
MDR Report Key11341177
MDR Text Key265990815
Report Number3003418325-2021-00003
Device Sequence Number1
Product Code NQR
Combination Product (y/n)N
PMA/PMN Number
P040034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberDSD5005
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/30/2021
Date Manufacturer Received07/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-